Immunome, Inc. (IMNM)
22.07
-0.14
(-0.63%)
USD |
NASDAQ |
Mar 03, 14:09
Immunome Shareholders Equity (Quarterly) : 263.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.220B |
| Scholar Rock Holding Corp. | 245.00M |
| Stoke Therapeutics, Inc. | 308.10M |
| Nurix Therapeutics, Inc. | 538.75M |
| Prelude Therapeutics, Inc. | 58.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 299.38M |
| Total Liabilities (Quarterly) | 35.46M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.902 |
| Net Debt Paydown Yield | -0.02% |